| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |